Effects of qian-kun-nin, a chinese herbal medicine formulation, on HIV positive subjects: a pilot study

American Journal of Chinese Medicine

Volumn 28, Issue 3-4, 2000, Pages 305-312

  Zhang, Liu ^a   Yuc, Shi Tao ^b   Xue, Yong Xin ^c   Attele, Anoja S ^d   Yuan, Chun Su ^d  

^a Entrei Institute of Traditional Chinese Medicine   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c Department of Medicine   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERBACEOUS AGENT; QIAN KUN NIN; QIAN-KUN-NIN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; MIDDLE AGED; PILOT STUDY; SAFETY; SATISFACTION; SINGLE BLIND PROCEDURE; VIROLOGY; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; CONSUMER PRODUCT SAFETY; DRUGS, CHINESE HERBAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERSONAL SATISFACTION; PILOT PROJECTS; SINGLE-BLIND METHOD; VIRAL LOAD;

EID: 0034572783     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/s0192415x00000362     Document Type: Article

References (16)

1. Bcnsky, D. and A. Gamble. Chinese Herbal Medicine: Materia Medica Eastland Press: Seattle, 1993.
2. Cao, Y., D.D. Ho and J. Todd. Clinical evaluation of branched DNA signal amplification for quantifying H1V type-1 in human plasma. AIDS Research and Human Retroviruses 11, 353-361, 1995.
3. Engvall, E. and P. Perlman. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immiinochemistry 8, 871-874, 1971.
4. Fauci, A.S., H. Masur, E.P. Gelmann, P.D. Markham, B.H. Hahn and H.C. Lane. NIH conference. The acquired immunodeficiency syndrome: an update. Annals of Internal Medicine 102,800-813,1985.
5. Fauci, A.S. and J.G. Artlett. Guideline for the use of antiretroviral agents in HIV-infected adults and adolescents. Annals of Internal Medicine 128, 1079-1100, 1998.
6. Hamada, M., H. Fujii, H. Yamamoto, Y. Miyazawa, S.M. Shui, Y.C. Tung and N. Yamaguchi. Effect of a Kanpo medicine, Zyuzentaihoto, on the immune reactivity of tumor-bearing mice. Journal of Ethnoplmrmacology 24, 311-320, 1988.
7. Haranaka, R., R. Hasegawa, A. Sakurai, N. Satomi and K. Haranaka. Antitumor activity of combination therapy with traditional Chinese medicine and OK 432 or MMC. Journal of Biological Response Modifiers 7, 77-90, 1988.
8. Ho, D.D., A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard, and M. Markowitz. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126, 1995.
9. Ito, H. and K. Shimura. Antitumor effects of Juzen-taiho-to (TJ-48) and other kampo medicines. In Hosoya E, Yamamura Y, eds. Recent Advances in the Pharmacology of Kampo (Japanese Herbal) Medicine. Tokyo, Excerpta Medico 281-290, 1988.
10. Kassler, W.J., P. Blance and R. Greenlatt. The use of medicinal herbs by human immunodeficiency virus-infected patients. Archiva Internal Medicine 151, 2281-2288, 1991.
11. Li, B.Q., T. Fu, Y.D. Yan, N.W. Oaylor, F.W. Ruscetti and H.F. Kung. Inhibition of H1V infection by baicalin-A flavonoid compound purified from Chinese herbal medicine. Cellular and Molecular Biology Research 39: 119-124, 1993.
12. Numata, M., A. Yamamoto, A. Moribayashi and H. Yamada. Antitumor components isolated from the Chinese Herbal Medicine CoL\ lachyma-jobi. Planta Medico 60, 356-359, 1994.
13. Phillips, L.G., M. Hllowaynichols and W.D. King. Herbs and HIV: The health food industry's answer. Southern MedicaUoiirnal 88(9), 911-913, 1995.
14. Salazar-Gonzalez, J.F., O. Martinez-Maza, P. Nishania, N. Aziz, L.-P. Shen, S. Grosser, J. Taylor, R. Dctels and J.L. Fahey. Increased immune activation precedes the infection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. Journal of Infectious Diseases 178,423-430, 1998.
15. Saxinger, C. and R.C. Gallo. Methods in laboratory investigation. Application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human t cell leukemia-lymphoma virus. Laboratory Investigation 49, 371-377, 1983.
16. Tatsuta, M., H. lishi, M. Baba, A. Nakaizumi and H. Uehara.. Inhibition by shi-quan-da-bu-tang (TJ-48) of experimental hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats. European Journal of Cancer 30A, 74-78, 1994.